Active surveillance research program for the assessment of the safety and the effectiveness of linagliptin

First published 29/07/2014

Last updated 05/10/2026

EU PAS number:

EUPAS5790

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

1218-0163_CTP_final-rule_Redacted.pdf

English (1.25 MB - PDF) View document

Study results

No information provided.

Study report

Abstract of study report

1218-0163_Synopsis.pdf

English (175.35 KB - PDF) View document

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Active surveillance research program for the assessment of the safety and the effectiveness of linagliptin

Secondary tabs

Share this page